Logo
PROSTATIC ARTERY EMBOLIZATION MARKET ANALYSIS
  2. / Market Insights
  3. Prostatic Artery Embolization Market Analysis
all report title image

PROSTATIC ARTERY EMBOLIZATION MARKET ANALYSIS

Prostatic Artery Embolization Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI4108
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market News

Key Developments-

  1. In 2018, Embolx, Inc., a medical device company, announced CE certification for its next generation of sniper balloon occlusion micro-catheters for treatment of enlarged prostate and cancerous tumors.
  2. In 2019, QX Medicals, a medical device company, acquired the rights of bioresorbable embolic technology developed by researchers at the University of Minnesota. This bioresorbable embolic technology is are used by interventional radiologist for prostatic artery embolization.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.